Crossmark

An azo bond primary cleavage and C–C bond secondary cleavage-based polymeric β-lapachone prodrug for selective anti-cancer therapy

Published Online: 2025-01-02

Published Print: 2025-02

Authors

Zhao, Weidong

Zheng, Mengfei

Chu, Hongyu

Zhang, Jingxuan

Wang, Kun

Yang, Chenguang

Shen, Na

Tang, Zhaohui
License Information

Text and Data Mining valid from 2025-01-02

Version of Record valid from 2025-01-02
More Information

Article History

Received: 9 September 2024

Accepted: 5 November 2024

First Online: 2 January 2025

Ethics

: Conflict of interest The authors declare that they have no conflict of interest.

Document is current